Advanced alpha-1A selective adrenoceptor antagonist in prolonged-release formulation for effective management of lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH).


Tamgo is a branded pharmaceutical product by Inspiron Scientific Pvt. Ltd. containing Tamsulosin Hydrochloride 0.4mg in prolonged-release tablet form. Tamsulosin is a highly selective alpha-1A adrenoceptor antagonist that specifically targets the smooth muscle of the prostate gland, bladder neck, and prostatic urethra to relieve lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH).
The prolonged-release formulation ensures consistent drug release over 24 hours, maintaining steady therapeutic plasma concentrations for all-day symptom relief with just one tablet daily. Tamsulosin’s high selectivity for alpha-1A receptors means it effectively relaxes prostate smooth muscle with minimal impact on blood pressure, making it one of the most well-tolerated treatments for BPH worldwide.
Everything healthcare professionals and patients need to know about Tamgo — from composition and mechanism of action to clinical benefits and administration guidelines.
Benign Prostatic Hyperplasia (BPH) is a common, non-cancerous enlargement of the prostate gland that affects men as they age. The prostate surrounds the urethra, and when it enlarges, it can squeeze or partially block the urethra, leading to bothersome lower urinary tract symptoms (LUTS) that can significantly impact quality of life if left untreated.
BPH is not prostate cancer and does not increase the risk of cancer. However, it can cause considerable discomfort and inconvenience. The dynamic component of BPH — increased smooth muscle tone mediated by alpha-1A adrenergic receptors — is the primary target of Tamgo (Tamsulosin HCl 0.4mg), which selectively relaxes these muscles to restore normal urine flow.

Recognizing the signs early can lead to timely treatment and better outcomes. Consult your doctor if you experience any of the following:
Tamgo works through a targeted mechanism to deliver rapid and sustained symptom relief by selectively acting on prostate alpha-1A receptors.
Discover Inspiron Scientific's complete range of pharmaceutical products.
Whether you're a healthcare provider seeking quality pharmaceutical products, a distributor exploring partnership opportunities, or a professional looking to join our team — we'd love to hear from you.
Our team is available to discuss how Inspiron Scientific can support your healthcare needs. Reach out today.
Fill out the form below and our team will contact you promptly.
At Inspiron Scientific, quality is non-negotiable. Every product in our portfolio is sourced from WHO-GMP certified manufacturing partners and undergoes rigorous quality assurance processes. We stand behind the safety, efficacy, and consistency of every medicine we deliver.